These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3742315)

  • 1. [Ceftriaxone in the treatment of severe infections].
    Germain M; Chaton P; Gobez N; Daversin P; Akli J; Coulée MD
    Cah Anesthesiol; 1986 May; 34(3):263-5. PubMed ID: 3742315
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of a combination of ceftriaxone (Rocephin) and ornidazole (Tiberal) in the treatment of severe intra-abdominal infections in surgery].
    Vyhnánek F; Lochmannn O; Procházka M; Absolonová V
    Cesk Epidemiol Mikrobiol Imunol; 1986 Sep; 35(5):299-306. PubMed ID: 2944632
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of ceftriaxone in severe infections in adults].
    Lacut JY; Dupon M; Quentin C; Brachet-Liermain A; Granger C; Echinard E
    Pathol Biol (Paris); 1986 May; 34(5):451-6. PubMed ID: 3534720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Netilmicin alone or in combination in renal transplantation.
    Stathakis C; Kosmidis J; Boletis J; Iatrou C; Metaxatos G; Vlassis T; Chomatas J; Vosnides G
    Chemioterapia; 1987 Jun; 6(2 Suppl):497-9. PubMed ID: 3334610
    [No Abstract]   [Full Text] [Related]  

  • 5. ["Single shot" prevention in abdominal surgery. Antibiotics with long half-life (ceftriaxone, ornidazole) vs. antibiotics with short half-life (cefazolin, metronidazole, clindamycin)].
    Schweizer W; Striffeler H; Lüdi D; Fröscher R
    Helv Chir Acta; 1994 Apr; 60(4):483-8. PubMed ID: 8034522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose prophylaxis with ceftriaxone and ornidazole in elective colon surgery.
    Reers B
    Chemioterapia; 1987 Jun; 6(2 Suppl):606-7. PubMed ID: 3509508
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ceftriaxone in the treatment of bacterial meningitis].
    Duniewicz M; Stanková M; Absolonová V; Lochmann O; Potuzník V; Brezinová J; Havlík J
    Cas Lek Cesk; 1986 Aug; 125(35):1093-6. PubMed ID: 3757000
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ceftriaxone and severe infections in medical resuscitation].
    Gardère JJ; de Barbeyrac B; Penouil F; Louis C; Brachet-Liermain A; Favarel-Garrigues JC
    Pathol Biol (Paris); 1987 May; 35(5):608-12. PubMed ID: 3302867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of orthopedic infections with ceftriaxone.
    Höckel S
    J Chemother; 1989 Jul; 1(4 Suppl):734. PubMed ID: 16312613
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ceftriaxone in the ambulatory treatment of bacterial infections].
    Santa Cruz Valverde PL; Cruz Abascal R
    Med Clin (Barc); 1993 May; 100(18):718. PubMed ID: 8492604
    [No Abstract]   [Full Text] [Related]  

  • 11. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections.
    Solomkin J; Zhao YP; Ma EL; Chen MJ; Hampel B;
    Int J Antimicrob Agents; 2009 Nov; 34(5):439-45. PubMed ID: 19692210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxon in the treatment of severe bacterial infections.
    Stafová J; Cizmárová L; Neubertová K; Karpenková H; Márová J; Procházková A; Vacek V
    Czech Med; 1986; 9(3):170-6. PubMed ID: 3095078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ceftriaxone in bacterial otorhinolaryngologic infections in comparison with lincomycin].
    Cenzi M
    G Ital Chemioter; 1985; 32(2):359-60. PubMed ID: 3833579
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppression in myelo-and lymphoproliferative disorders.
    Papa G; Cudillo L; Rainaldi A; Dentamaro T
    Rays; 1994; 19(4):417-23. PubMed ID: 7871218
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone-related agranulocytosis during outpatient parenteral antibiotic therapy.
    Duncan CJ; Evans TJ; Seaton RA
    J Antimicrob Chemother; 2010 Nov; 65(11):2483-4. PubMed ID: 20810422
    [No Abstract]   [Full Text] [Related]  

  • 18. Pre-operative single-dose broad spectrum prophylaxis with ceftriaxone and ornidazole in elective colon surgery.
    Reers B; Sulkowski U; Holzgreve A; Winde G
    J Chemother; 1989 Jul; 1(4 Suppl):1007-8. PubMed ID: 16312745
    [No Abstract]   [Full Text] [Related]  

  • 19. Experiences with ceftriaxone (rocephin) in perioperative antibiotic prophylaxis for elective colon surgery.
    Renner H; Lösch H
    J Chemother; 1989 Jul; 1(4 Suppl):1005-6. PubMed ID: 16312744
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical trial of ceftriaxone in different bacterial infections.
    Kavakas H; Ellinas C; Matzakos K; Politikou L; Sahin A
    J Chemother; 1989 Jul; 1(4 Suppl):658-9. PubMed ID: 16312579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.